CLINICAL_TRIALS
trial_result
· 2013-05-29
Clinical Trial Update: Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia [Phase 3]
Summary
Phase 3 trial evaluating risk-adapted combination chemotherapy for young patients with acute lymphoblastic leukemia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University Hospital Schleswig-Holstein | Conditions: Leukemia | Phase 3 | Status: COMPLETED